Pay in 4 interest-free payments of $7.44 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
**Lot certified by HPLC certificate of analysis exceeding 99%, mass spectrometry confirming theoretical molecular weight (BPC-157: 1419.53 Da / TB-500 fragment: supplier-dependent, full thymosin beta-4: 4963 Da), cold chain maintained from synthesis to delivery.** Unique dual-lyophilized vial, two-minute reconstitution, aliquoting supported to extend functional shelf life
Research overview Related protocols and comparisons Ipamorelin (5 mg Vial) Dosage Protocol Ipamorelin (10 mg Vial) Dosage Protocol Tesamorelin 5mg + Ipamorelin 5mg (10mg Blend) Dosage Protocol CJC-1295 DAC (5 mg) + Ipamorelin (5 mg) Stack Dosage Protocol CJC-1295 DAC (2 mg) + Ipamorelin (5 mg) Stack Dosage Protocol AOD-9604 + CJC-1295 + Ipamorelin (12 mg Blend) Dosage Protocol CJC-1295 NO DAC (5 mg Vial) Dosage Protocol
High enough to be bacteriostatic (inhibiting bacterial growth) without being bactericidal (killing bacteria outright at first contact)
Mild local reactions at the injection site typically resolve quickly and are most often related to injection technique rather than the product itself
What are the reported side effects
Some practitioners suggest cycling, with a 6-12 week usage period followed by a 4-8 week break between cycles
